March 2016 FDA Recall Drug by Purdue Pharma L.p.
D-0810-2016 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Purdue Pharma L.p. on March 31, 2016 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in U.S. Including: FL, LA, MI, MS, NC, NJ, OH and SC. and the recall is currently terminated.

Recall Number: D-0810-2016

Reason for Recall
Failed Dissolution Specifications
Initiated
03-31-2016
Reported
04-13-2016
Quantity
2172 Cartons

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
73709
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Purdue Pharma L.P.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
U.S. Including: FL, LA, MI, MS, NC, NJ, OH and SC.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
04-12-2017
Product Description About Product Description
Full technical description of the product.
Intermezzo (zolpidem tartrate) sublingual tablet 1.75 mg, CIV, 30 Ct Cartons, Rx Only. Dist by Purdue Pharma L.P., Stamford, CT 06901-3431. NDC: 59011-256-30.

Batch or Lot Expiration Information

Lot# : 3126431B, Expiry: 09/30/17